-+ 0.00%
-+ 0.00%
-+ 0.00%

*EnGene Therapeutics; Initiation of BLA Submission for Detalimogene Planned for 4Q 2026 >ENGN

Dow Jones·09/08/2026 11:39:00

Please log in to view news